Great to see @ednacukierman from @FoxChaseCancer at her poster at #AACR19. Here's her poster if you missed it https://t.co/4DZhtbfB0d
and don't miss her podium presentation tomorrow at 2:05 p.m. in B405 https://t.co/MuJ0ZXnLDz
Another @FoxChaseCancer poster at #AACR19 from Fox Chase Fellow Alexander Deneka (Erica Golemis lab) on the impact of Nedd9 on NSCLC in murine models. Poster up until 12 p.m. at section 39 board number 13. https://t.co/LPrHaVyodl
Congratulations to @FoxChaseCancer fellow Alexander Y. Deneka (from the lab of Erica Golemis) on his oral presentation at #AACR19. His oral abstract: https://t.co/LDEOkjzZyj. Don't miss his poster on Monday in the exhibit hall 1830/13: https://t.co/LPrHaVyodl
If you are at #ASCO18 today don't miss the poster in HALL A until 11:30 a.m. from @FoxChaseCancer Namrata Vijayvergia "Pembrolizumab monotherapy in patients with previously treated metastatic high grade neuroendocrine neoplasms." Poster #293
If at #ASCO18 today don't miss the poster in HALL A until 11:30 a.m. from @FoxChaseCancer "A two-part open-label, randomized phase 2/3 study of dinutuximab and irinotecan for second-line treatment of subjects with relapsed or refractory small cell lung cancer." Board #190a
@djsampson@sxbegle It's also an overused term to hype up things that aren't really news, but in a world where there are fewer and fewer journalists and the whole world can read their stories it may help get the harder stories out there.
If you are at #ASCO18 don't miss @HosseinBorghaei in the Lung Cancer Educational Session https://t.co/Chu4BLqNAf HALL D1 3:25 p.m. CT. "Novel Immunotherapy Combinations in the Initial Management of Non-Small Cell Lung Cancer @FoxChaseCancer